Capstone Investment Advisors, LLC Abb Vie Inc. Put Options Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $1.63 Million - $1.9 Million	-10,500 Reduced 3.86%	261,200 $44.8 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $17.5 Million - $19.9 Million	-109,400 Reduced 28.71%	271,700 $49.5 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $6.82 Million - $7.69 Million	49,600 Added 14.96%	381,100 $59.1 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $17.3 Million - $20.1 Million	129,700 Added 64.27%	331,500 $49.4 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $2.09 Million - $2.61 Million	15,800 Added 8.49%	201,800 $27.2 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $245,837 - $283,118	-1,700 Reduced 0.91%	186,000 $29.6 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $484,085 - $580,545	3,500 Added 1.9%	187,700 $30.4 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $7.9 Million - $9.07 Million	-58,900 Reduced 24.23%	184,200 $24.7 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $91.5 Million - $116 Million	-665,200 Reduced 73.24%	243,100 $37.2 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $118 Million - $146 Million	-890,700 Reduced 49.51%	908,300 $147 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $53.3 Million - $67.4 Million	496,200 Added 38.09%	1,799,000 $244 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $9.53 Million - $10.8 Million	-89,600 Reduced 6.43%	1,302,800 $141 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $22.6 Million - $25.2 Million	214,600 Added 18.22%	1,392,400 $157 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $26.9 Million - $29.6 Million	262,800 Added 28.72%	1,177,800 $127 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $35.9 Million - $48.4 Million	445,800 Added 95.01%	915,000 $98 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $5.67 Million - $6.65 Million	-66,000 Reduced 12.33%	469,200 $41.1 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $32.4 Million - $43.4 Million	442,100 Added 474.87%	535,200 $52.5 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $36.4 Million - $55.1 Million	-563,800 Reduced 85.83%	93,100 $7.09 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $15.4 Million - $19.2 Million	213,000 Added 47.98%	656,900 $58.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $7.56 Million - $9.09 Million	120,100 Added 37.09%	443,900 $33.6 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $7.12 Million - $9.1 Million	108,400 Added 50.32%	323,800 $23.5 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $4.9 Million - $5.77 Million	63,500 Added 41.8%	215,400 $17.4 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $2.46 Million - $3.03 Million	31,600 Added 26.27%	151,900 $14 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $7.66 Million - $8.52 Million	86,200 Added 252.79%	120,300 $11.4 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $3.06 Million - $3.62 Million	34,100 New	34,100 $3.16 Million

Others Institutions Holding ABBV

# of Institutions

3,808

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.94M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account